Share this program:

Self-Paced Online

Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients

Share this program:

Register now for immediate access to this program.

Register Now

Already Registered?

Login
Price

$30 for Members
$50 for Non-Members
$75 for Non-Member Group Pricing
$60 for Member Group Pricing

60 minutes
Date Published

October 30, 2019

Publisher

Pediatric Pharmacy Association

Subjects

Cannabinoid, Hyperemesis, Opioids, Overdose, Pediatrics

Questions

For immediate assistance please consult our FAQ page. If you're unable to find the answer you need, please call 737-201-2059 (M-F, 8am-6pm CT) or e-mail customer service.

Summary

Dr. Justin Reinert, PharmD, BCCCP will conduct a 1 hour knowledge-based continuing education webinar program on the Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients. In the current environment of legislative action surrounding opioids and marijuana, clinicians must remain cognizant of trends regarding medications and substances of abuse. Restrictive access to opioid medications, in addition to the legalization of medical and recreational marijuana in select states, has undoubtedly altered the presentation and subsequent management of the overdose patient. Pediatric patients, specifically adolescents and teens, may be particularly likely to explore historically non-traditional drugs and substances. This program will discuss national overdose data, as well as the management of loperamide toxicity and cannabinoid hyperemesis syndrome with regard to pediatric patients.

Learning Objectives:
At the end of this session, participants will be able to:
1. Identify the mechanism of toxicity and typical toxidrome associated with loperamide and cannabinoid hyperemesis syndrome.
2. Describe treatment modalities for the management of loperamide toxicity and cannabinoid hyperemesis syndrome.
3. Articulate medications and fluids that can be administered via hypodermoclysis for the management of loperamide toxicity and cannabinoid hyperemesis syndrome.

Accreditation:
ACPE logo PPAG has accredited this knowledge-based webinar for 1.0 contact hours (0.10 CEUs) of continuing education credit for pharmacists. UAN #: 0180-0000-19-012-H01-P

The Pediatric Pharmacy Advocacy Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. In order to receive credit, participants must register for the program, attend the program, and fill out a post-program survey. Webinar programs are 100% supported through program registration fees and PPAG membership dues, and is not supported by Industry.

Group Pricing: Group pricing is available through online registration for CE only. Groups will need to email Lauren Henretty at lhenretty@pediatricpharmacy.org their attendance list with each participants name, email, NABP# and DOB in order to receive credit.

Expand summary
back to top

Presenters

Justin P. Reinert, PharmD, BCCCP

Dr. Justin Reinert is a Clinical Assistant Professor at the Ben and Maytee Fisch College of Pharmacy at the University of... Read More

back to top

Program Titles and Supporting Materials

This program contains the following components:

Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients - Video
Management of Loperamide Toxicity and Cannabinoid Hyperemesis Syndrome in Pediatric Patients - Paper
back to top

Credit

If applicable, you may obtain credit in multiple jurisdictions simultaneously for this program (see pending/approved list below). If electing credit for this program, registrants in jurisdictions not listed below will receive a Certificate of Completion that may or may not meet credit requirements in other jurisdictions. Where applicable, credit will be only awarded to a paid registrant completing all the requirements of the program as determined by the selected accreditation authority.

back to top

How to Attend

Join the self-paced program from your office, home, or hotel room using a computer and high speed internet connection. You may start and stop the program at your convenience, continue where you left off, and review supporting materials as often as you like. Please note: Internet Explorer is no longer a supported browser. We recommend using Google Chrome, Mozilla Firefox or Safari for best results.

Technical Requirements
You may access this course on a computer or mobile device with high speed internet (iPhones require iOS 10 or higher). Recommended browsers are Google Chrome or Mozilla Firefox.

back to top

More

Refund Policy
SeminarWeb and Pediatric Pharmacy Association programs are non-refundable.

Privacy Statement
We respect and are committed to protecting your privacy. Read Statement.